Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders

Eur J Haematol Suppl. 2007 Oct:(68):5-8. doi: 10.1111/j.1600-0609.2007.00935.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Janus Kinase 2 / genetics*
  • Janus Kinase 2 / metabolism
  • Mutation
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / physiopathology*
  • Signal Transduction*

Substances

  • Janus Kinase 2